594 related articles for article (PubMed ID: 2760204)
1. Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus.
Buyon JP; Ben-Chetrit E; Karp S; Roubey RA; Pompeo L; Reeves WH; Tan EM; Winchester R
J Clin Invest; 1989 Aug; 84(2):627-34. PubMed ID: 2760204
[TBL] [Abstract][Full Text] [Related]
2. Neonatal lupus: bedside to bench and back.
Buyon JP
Scand J Rheumatol; 1996; 25(5):271-6. PubMed ID: 8921918
[TBL] [Abstract][Full Text] [Related]
3. Maternal autoimmune response to recombinant Ro/SSA and La/SSB proteins in Japanese neonatal lupus erythem atosus.
Miyagawa S; Fukumoto T; Hashimoto K; Hachiya T; Yoshioka A; Shirai T
Autoimmunity; 1995; 21(4):277-82. PubMed ID: 8852519
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies of neonatal lupus erythematosus.
Lee LA; Frank MB; McCubbin VR; Reichlin M
J Invest Dermatol; 1994 Jun; 102(6):963-6. PubMed ID: 8006461
[TBL] [Abstract][Full Text] [Related]
5. Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies.
Cimaz R; Spence DL; Hornberger L; Silverman ED
J Pediatr; 2003 Jun; 142(6):678-83. PubMed ID: 12838197
[TBL] [Abstract][Full Text] [Related]
6. Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block.
Dörner T; Chaoui R; Feist E; Göldner B; Yamamoto K; Hiepe F
J Autoimmun; 1995 Oct; 8(5):675-84. PubMed ID: 8579723
[TBL] [Abstract][Full Text] [Related]
7. Autoantibody response to the Ro/La particle may predict outcome in neonatal lupus erythematosus.
Silverman ED; Buyon J; Laxer RM; Hamilton R; Bini P; Chu JL; Elkon KB
Clin Exp Immunol; 1995 Jun; 100(3):499-505. PubMed ID: 7774062
[TBL] [Abstract][Full Text] [Related]
8. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies.
Buyon JP; Winchester RJ; Slade SG; Arnett F; Copel J; Friedman D; Lockshin MD
Arthritis Rheum; 1993 Sep; 36(9):1263-73. PubMed ID: 8216420
[TBL] [Abstract][Full Text] [Related]
9. 52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block.
Fritsch C; Hoebeke J; Dali H; Ricchiuti V; Isenberg DA; Meyer O; Muller S
Arthritis Res Ther; 2006; 8(1):R4. PubMed ID: 16356190
[TBL] [Abstract][Full Text] [Related]
10. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
[TBL] [Abstract][Full Text] [Related]
11. [Congenital heart block associated with maternal anti SSA/SSB antibodies :a report of four cases].
Ayed K; Gorgi Y; Sfar I; Khrouf M
Pathol Biol (Paris); 2004 Apr; 52(3):138-47. PubMed ID: 15063933
[TBL] [Abstract][Full Text] [Related]
12. Importance of the immune response to the Ro/La particle in the development of congenital heart block and neonatal lupus erythematosus.
Silverman E; Mamula M; Hardin JA; Laxer R
J Rheumatol; 1991 Jan; 18(1):120-4. PubMed ID: 2023181
[TBL] [Abstract][Full Text] [Related]
13. Detection of autoantibodies to Ro(SS-A), La(SS-B) and U1RNP in different congenital heart rhythm disorders using immunoblot and enzyme immunoassay.
Dörner T; Trebeljahr G; Göldner B; Yamamoto K; Apostoloff E; Hiepe F
J Autoimmun; 1994 Feb; 7(1):93-106. PubMed ID: 8198704
[TBL] [Abstract][Full Text] [Related]
14. A serologic marker for fetal risk of congenital heart block.
Salomonsson S; Dörner T; Theander E; Bremme K; Larsson P; Wahren-Herlenius M
Arthritis Rheum; 2002 May; 46(5):1233-41. PubMed ID: 12115229
[TBL] [Abstract][Full Text] [Related]
15. Neonatal lupus erythematosus: studies on HLA class II genes and autoantibody profiles in Japanese mothers.
Miyagawa S; Shinohara K; Kidoguchi K; Fujita T; Fukumoto T; Hashimoto K; Yoshioka A; Shirai T
Autoimmunity; 1997; 26(2):95-101. PubMed ID: 9546818
[TBL] [Abstract][Full Text] [Related]
16. Target antigens of the SSA/Ro and SSB/La system.
Ben-Chetrit E
Am J Reprod Immunol; 1992; 28(3-4):256-8. PubMed ID: 1285896
[TBL] [Abstract][Full Text] [Related]
17. Anti-Ro (SSA) and anti-La (SSB) antibodies and complete congenital heart block.
Finkelstein Y; Adler Y; Harel L; Nussinovitch M; Youinou P
Ann Med Interne (Paris); 1997; 148(3):205-8. PubMed ID: 9255327
[TBL] [Abstract][Full Text] [Related]
18. Induction of antibodies reactive with SSA/Ro-SSB/La and development of congenital heart block in a murine model.
Miranda-Carús ME; Boutjdir M; Tseng CE; DiDonato F; Chan EK; Buyon JP
J Immunol; 1998 Dec; 161(11):5886-92. PubMed ID: 9834068
[TBL] [Abstract][Full Text] [Related]
19. Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies.
Strandberg L; Salomonsson S; Bremme K; Sonesson S; Wahren-Herlenius M
Lupus; 2006; 15(6):346-53. PubMed ID: 16830880
[TBL] [Abstract][Full Text] [Related]
20. Anti-Ro/SS-A and anti-La/SS-B autoantibody levels in relation to systemic lupus erythematosus disease activity and congenital heart block. A longitudinal study comprising two consecutive pregnancies in a patient with systemic lupus erythematosus.
Derksen RH; Meilof JF
Arthritis Rheum; 1992 Aug; 35(8):953-9. PubMed ID: 1642661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
